Health Care & Life Sciences » Pharmaceuticals | Medical & Biological Laboratories Co. Ltd.

Medical & Biological Laboratories Co. Ltd. | Income Statement

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
Sales/Revenue
7,172
7,611
8,057
7,349
7,072
Cost of Goods Sold (COGS) incl. D&A
3,160
3,405
3,561
3,121
3,066
Gross Income
4,012
4,206
4,496
4,228
4,006
SG&A Expense
4,531
5,045
4,864
4,149
3,885
EBIT
519
840
368
80
121
Unusual Expense
41
6
557
192
16
Non Operating Income/Expense
77
172
170
11
80
Interest Expense
37
36
39
27
18
Pretax Income
467
733
1,109
227
32
Income Tax
45
39
37
37
27
Consolidated Net Income
422
772
1,146
189
59
Net Income
419
766
1,142
189
59
Net Income After Extraordinaries
419
766
1,142
189
59
Net Income Available to Common
419
766
1,142
189
59
EPS (Basic)
81.00
148.10
220.85
36.50
11.49
Basic Shares Outstanding
5
5
5
5
5
EPS (Diluted)
80.99
148.10
220.86
36.50
11.49
Diluted Shares Outstanding
5
5
5
5
5
EBITDA
1
319
148
503
500
Non-Operating Interest Income
16
16
10
14
19
Minority Interest Expense
-
4
6
4
-
Equity in Affiliates (Pretax)
44
51
15
20
59

About Medical & Biological Laboratories Co.

View Profile
Address
KDX Nagoya Sakae Building, 10/F
Nagoya Aichi 460
Japan
Employees -
Website http://www.mbl.co.jp
Updated 09/14/2018
Medical & Biological Laboratories Co., Ltd. engages in the research, development, manufacture and sale of biological products. It operates through the Reagents and Investment segments. The Reagent segment supplies, manufactures, and sells clinical reagents and research reagents, and its related equipment and instruments.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.